668 related articles for article (PubMed ID: 29271278)
1. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
Ardabili HR; Gargari BP; Farzadi L
Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
[TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Yavuz DG
J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
[TBL] [Abstract][Full Text] [Related]
5. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Vitamin D Supplementation on Insulin Resistance among Women with Polycystic Ovary Syndrome.
Salehpour S; Hosseini S; Nazari L; Hosseini M; Saharkhiz N
JBRA Assist Reprod; 2019 Aug; 23(3):235-238. PubMed ID: 31091067
[TBL] [Abstract][Full Text] [Related]
8. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Maktabi M; Chamani M; Asemi Z
Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
[TBL] [Abstract][Full Text] [Related]
10. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
[TBL] [Abstract][Full Text] [Related]
11. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.
Belenchia AM; Tosh AK; Hillman LS; Peterson CA
Am J Clin Nutr; 2013 Apr; 97(4):774-81. PubMed ID: 23407306
[TBL] [Abstract][Full Text] [Related]
12. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial.
Trummer C; Schwetz V; Kollmann M; Wölfler M; Münzker J; Pieber TR; Pilz S; Heijboer AC; Obermayer-Pietsch B; Lerchbaum E
Eur J Nutr; 2019 Aug; 58(5):2019-2028. PubMed ID: 29946756
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
[TBL] [Abstract][Full Text] [Related]
14. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.
Raja-Khan N; Shah J; Stetter CM; Lott ME; Kunselman AR; Dodson WC; Legro RS
Fertil Steril; 2014 Jun; 101(6):1740-6. PubMed ID: 24636395
[TBL] [Abstract][Full Text] [Related]
15. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
16. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome.
Karamali M; Ashrafi M; Razavi M; Jamilian M; Akbari M; Asemi Z
Exp Clin Endocrinol Diabetes; 2017 May; 125(5):316-321. PubMed ID: 28407660
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
20. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
